OICR News / Tag

Clinical trials

Browse news tagged Clinical trials.

Browse all news

Filters

Discover the latest news and insightsDiscover the latest news and insights

All Collaboration Commercialization Talent Technology

All Video Article

Tagged stories

CollaborationClinical trials

Canadian Remote Access Framework for Clinical Trials brings new opportunities for cancer patients residing in rural and remote communities

The Canadian Cancer Clinical Trials Network (3CTN), has launched the proof-of-concept phase of the Canadian Remote Access Framework for Clinical Trials (CRAFT), which aims to broaden trial options for eligible cancer patients, regardless of where…

ArticleMay 06, 2021

TechnologyProstate cancer

Clinical trial: Using MRI for prostate cancer diagnosis equals or beats current standard

Phase III clinical trial of men with a clinical suspicion of prostate cancer finds MRI with targeted biopsies to be more accurate at diagnosis and less intrusive than current standard Toronto – (February 4, 2021)…

ArticleFeb 04, 2021

TechnologyOvarian cancer

Evolving treatment to evolving tumours: How OICR-supported researchers are getting ahead of ovarian cancer

OICR-supported Phase II trial uncovers how ovarian cancers become resistant to treatment, identifies new opportunities to personalize treatment for future patients Clinician investigator Dr. Stephanie Lheureux has seen many women fight ovarian cancer – some…

ArticleJul 27, 2020

TechnologyBreast cancer

Using the “window of opportunity” to understand biomarkers and tumour biology

OICR researchers have recently teamed up with a team of medical oncologists and surgeons at The Ottawa Hospital to launch a new breast cancer clinical trial – one that begins before a patient undergoes surgery. …

ArticleSep 11, 2019

TechnologyProstate cancer

What could we do if we had a clearer picture of prostate cancer?

OICR-supported trial finds new, more sensitive imaging technique can inform treatment decisions and benefit those with recurring prostate cancer Prostate cancer is the most common type of cancer found in men, but managing the disease…

ArticleMay 17, 2019

CommercializationBlood cancers

First-in-class drug for blood cancers discovered by Ontario researchers receives record-setting industry investment

Years of hard work by OICR’s Drug Discovery group and Ontario partners moves potential new treatment for leukemia towards clinical trials On January 29, 2019, Celgene Corporation made an investment of up to US$1 billion…

ArticleJan 29, 2019

← Previous Next stories →

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Clinical trials

Discover the latest news and insightsDiscover the latest news and insights

Tagged stories

Canadian Remote Access Framework for Clinical Trials brings new opportunities for cancer patients residing in rural and remote communities

Clinical trial: Using MRI for prostate cancer diagnosis equals or beats current standard

Evolving treatment to evolving tumours: How OICR-supported researchers are getting ahead of ovarian cancer

Using the “window of opportunity” to understand biomarkers and tumour biology

What could we do if we had a clearer picture of prostate cancer?

First-in-class drug for blood cancers discovered by Ontario researchers receives record-setting industry investment﻿

First-in-class drug for blood cancers discovered by Ontario researchers receives record-setting industry investment